Abstract: Federated weakly supervised video anomaly detection represents a significant advancement in privacy-preserving collaborative learning, enabling distributed clients to train anomaly detectors ...
Recursion is currently expanding the population and potentially can further optimize the dosing schedule. Given the invasive current standard of care and a high unmet need (min 50K in the US), the ...
Ailsa Ostovitz has been accused of using AI on three assignments in two different classes this school year. "It's mentally exhausting because it's like I know this is my work," says Ostovitz, 17. "I ...
Generative artificial intelligence has set off a tremendous amount of excitement, speculation, and anxiety thanks to its ability to convincingly mimic human work, including human writing. Although a ...
OpenCV is a set of libs written in C++ and the compiled into platform-native lib format: *.dll - for Windows, or *.dylib - for Linux / Mac OS. They can be accessed from Java via Java wrapper included ...
Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...
Why would you want to detect metal? Oh, I don't know … maybe you want to find some gold in the ground. You could dig up ALL the dirt, or you could find the location that has the gold before you dig.
What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
"This is the moment where the metal detector has gone off and you've dug up something shiny. You still need to find out exactly what you've got — but you've got something to work with." When you ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...